A detailed history of Keudell transactions in Novo Nordisk A S stock. As of the latest transaction made, Keudell holds 7,719 shares of NVO stock, worth $888,611. This represents 0.32% of its overall portfolio holdings.

Number of Shares
7,719
Previous 7,729 0.13%
Holding current value
$888,611
Previous $992,000 10.99%
% of portfolio
0.32%
Previous 0.3%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$122.71 - $146.91 $1,227 - $1,469
-10 Reduced 0.13%
7,719 $1.1 Million
Q1 2024

May 07, 2024

SELL
$102.11 - $135.92 $5,616 - $7,475
-55 Reduced 0.71%
7,729 $992,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $1,843 - $2,214
21 Added 0.27%
7,784 $805,000
Q3 2023

Oct 18, 2023

BUY
$90.94 - $199.54 $523,541 - $1.15 Million
5,757 Added 286.99%
7,763 $705,000
Q2 2023

Jul 20, 2023

BUY
$155.98 - $172.65 $85,633 - $94,784
549 Added 37.68%
2,006 $324,000
Q1 2023

Apr 18, 2023

BUY
$132.34 - $159.14 $192,819 - $231,866
1,457 New
1,457 $231,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $260B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Keudell Portfolio

Follow Keudell and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.